Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 176

1.

Vaginal drug delivery: strategies and concerns in polymeric nanoparticle development.

Wong TW, Dhanawat M, Rathbone MJ.

Expert Opin Drug Deliv. 2014 Sep;11(9):1419-34. doi: 10.1517/17425247.2014.924499. Epub 2014 Jun 24. Review.

PMID:
24960192
2.

Vaginal mucoadhesive drug delivery systems.

de Araújo Pereira RR, Bruschi ML.

Drug Dev Ind Pharm. 2012 Jun;38(6):643-52. doi: 10.3109/03639045.2011.623355. Epub 2011 Oct 15. Review.

PMID:
21999572
3.

Mucoadhesive nanosystems for vaginal microbicide development: friend or foe?

das Neves J, Amiji M, Sarmento B.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2011 Jul-Aug;3(4):389-99. doi: 10.1002/wnan.144. Epub 2011 Apr 19. Review.

PMID:
21506290
4.

Strategies for improving mucosal drug delivery.

Laffleur F, Bernkop-Schnürch A.

Nanomedicine (Lond). 2013 Dec;8(12):2061-75. doi: 10.2217/nnm.13.178. Review.

PMID:
24279493
5.

Strategies to prolong the intravaginal residence time of drug delivery systems.

Baloglu E, Senyigit ZA, Karavana SY, Bernkop-Schnürch A.

J Pharm Pharm Sci. 2009;12(3):312-36. Review.

6.

Advanced topical drug delivery system for the management of vaginal candidiasis.

Johal HS, Garg T, Rath G, Goyal AK.

Drug Deliv. 2016;23(2):550-63. doi: 10.3109/10717544.2014.928760. Epub 2014 Jun 24. Review.

PMID:
24959937
7.

Mucoadhesive vaginal drug delivery systems.

Acartürk F.

Recent Pat Drug Deliv Formul. 2009 Nov;3(3):193-205. Review.

PMID:
19925443
8.

Exploring novel approaches to vaginal drug delivery.

Gupta S, Gabrani R, Ali J, Dang S.

Recent Pat Drug Deliv Formul. 2011 May;5(2):82-94. Review.

PMID:
21413924
9.

Enhanced vaginal drug delivery through the use of hypotonic formulations that induce fluid uptake.

Ensign LM, Hoen TE, Maisel K, Cone RA, Hanes JS.

Biomaterials. 2013 Sep;34(28):6922-9. doi: 10.1016/j.biomaterials.2013.05.039. Epub 2013 Jun 13.

11.

Mucoadhesive microspheres: a promising tool in drug delivery.

Patil SB, Sawant KK.

Curr Drug Deliv. 2008 Oct;5(4):312-8. Review.

PMID:
18855602
12.

Therapeutic potential of mucoadhesive drug delivery systems--an updated patent review.

Maurya SK, Pathak K, Bali V.

Recent Pat Drug Deliv Formul. 2010 Nov;4(3):256-65. Review.

PMID:
20649509
13.

Intravesical drug delivery: Challenges, current status, opportunities and novel strategies.

GuhaSarkar S, Banerjee R.

J Control Release. 2010 Dec 1;148(2):147-59. doi: 10.1016/j.jconrel.2010.08.031. Epub 2010 Sep 8. Review.

PMID:
20831887
14.

Spray-dried powders enhance vaginal siRNA delivery by potentially modulating the mucus molecular sieve structure.

Wu N, Zhang X, Li F, Zhang T, Gan Y, Li J.

Int J Nanomedicine. 2015 Aug 26;10:5383-96. doi: 10.2147/IJN.S87978. eCollection 2015 Aug 26.

15.

Formulation studies of benzydamine mucoadhesive formulations for vaginal administration.

Perioli L, Ambrogi V, Venezia L, Giovagnoli S, Pagano C, Rossi C.

Drug Dev Ind Pharm. 2009 Jul;35(7):769-79. doi: 10.1080/03639040802592435.

PMID:
19337872
16.

Mucoadhesive drug delivery systems.

Hombach J, Bernkop-Schnürch A.

Handb Exp Pharmacol. 2010;(197):251-66. doi: 10.1007/978-3-642-00477-3_9. Review.

PMID:
20217533
17.

Nanotechnological strategies for vaginal administration of drugs--a review.

da Silva PB, Ramos MA, Bonifácio BV, Negri KM, Sato MR, Bauab TM, Chorilli M.

J Biomed Nanotechnol. 2014 Sep;10(9):2218-43. Review.

PMID:
25992455
18.

Advances in mucoadhesion and mucoadhesive polymers.

Khutoryanskiy VV.

Macromol Biosci. 2011 Jun 14;11(6):748-64. doi: 10.1002/mabi.201000388. Epub 2010 Dec 27. Review.

PMID:
21188688
19.

Nano-sized platforms for vaginal drug delivery.

El-Hammadi MM, Arias JL.

Curr Pharm Des. 2015;21(12):1633-44. Review.

PMID:
25354177
20.

pH-sensitive Eudragit nanoparticles for mucosal drug delivery.

Yoo JW, Giri N, Lee CH.

Int J Pharm. 2011 Jan 17;403(1-2):262-7. doi: 10.1016/j.ijpharm.2010.10.032. Epub 2010 Oct 31.

PMID:
20971177

Supplemental Content

Support Center